Island Pharmaceuticals Ltd (ILA) - Total Liabilities

Latest as of June 2025: AU$336.43K AUD ≈ $238.04K USD

Based on the latest financial reports, Island Pharmaceuticals Ltd (ILA) has total liabilities worth AU$336.43K AUD (≈ $238.04K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Island Pharmaceuticals Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Island Pharmaceuticals Ltd - Total Liabilities Trend (2019–2024)

This chart illustrates how Island Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.

Island Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Island Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Easy Field TWO:6425	Taiwan	NT$1.56 Billion
Amata Summit Growth Freehold and Leasehold Real Estate Investment Trust BK:AMATAR	Thailand	฿1.07 Billion
DYO Boya Fabrikalari Sanayi ve Ticaret AS IS:DYOBY	Turkey	TL11.92 Billion
Greenheart Gold Inc. V:GHRT	Canada	CA$2.24 Million
I-Tech ST:ITECH	Sweden	Skr28.66 Million
APCB Inc TW:6108	Taiwan	NT$3.25 Billion
Columbus Acquisition Corp Unit NASDAQ:COLAU	USA	$310.21K
ATM Grupa S.A. WAR:ATG	Poland	zł111.62 Million

Liability Composition Analysis (2019–2024)

This chart breaks down Island Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Island Pharmaceuticals Ltd (ILA) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	22.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Island Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Island Pharmaceuticals Ltd (2019–2024)

The table below shows the annual total liabilities of Island Pharmaceuticals Ltd from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$336.43K ≈ $238.04K	-67.83%
2023-12-31	AU$1.05 Million ≈ $739.85K	+296.30%
2022-12-31	AU$263.85K ≈ $186.69K	-54.57%
2021-12-31	AU$580.73K ≈ $410.91K	+145.21%
2020-12-31	AU$236.83K ≈ $167.57K	+35037.98%
2019-12-31	AU$674.00 ≈ $476.90	--

About Island Pharmaceuticals Ltd

AU:ILA Australia Biotechnology

Market Cap

$84.72 Million

AU$119.73 Million AUD

Market Cap Rank

#19800 Global

#644 in Australia

Share Price

AU$0.45

Change (1 day)

+7.23%

52-Week Range

AU$0.18 - AU$0.57

All Time High

AU$0.57